Category Archives: PR NEWSWIRE

Global Egg Powder Market is Expected to Reach US$ 1,200 Million by 2025 – Persistence Market Research

http://photos.prnewswire.com/prnc/20161114/438683LOGONEW YORK, December 13, 2017 /PRNewswire/ —
A new research report by Persistence Market Research gives a snapshot of the global egg powder market, which includes products such as whole egg powder, egg yolk powder, egg albumen powder, and egg powder mix or a blend of egg powder. The…

PR NEWSWIRE

Tempo Quest, Inc. Closes Preferred Seed Financing Round

BOULDER, Colo., Dec. 13, 2017 /PRNewswire/ — Tempo Quest, Inc. today announced that it has closed its preferred seed financing round for a total of $2.5 million.  Investors include SCubed Capital, LLC, Menlo Park, CA; and a group of individual angel investors including Bob Pavey and…

PR NEWSWIRE

Gallium Nitride Semiconductor Devices Market Worth $4.3 Billion by 2025: Grand View Research, Inc.

http://photos.prnewswire.com/prnc/20160524/371361LOGOSAN FRANCISCO, December 13, 2017 /PRNewswire/ —
The global gallium nitride (GaN) semiconductor devices market is expected to reach USD 4.37 billion by 2025, according to a new study by Grand View Research, Inc. The growing applications of GaN in a wide variety of semiconductor…

PR NEWSWIRE

Réveillon du Nouvel an : les destinations clés par avion en 2016 et les tendances Expedia pour cette année

Expedia Logo– Le top 10 des destinations par avion des Francais en 2016
– Les tendances pour 2017 en France et chez nos voisins européens 
PARIS, 13 décembre 2017 /PRNewswire/ — Selon les données Expedia 2016, Rome, puis Londres et Barcelone trônaient en tête de liste des destinations pa…

PR NEWSWIRE

Massive Projection In Sedona, "The Most Beautiful Place On Earth"

Sedona Northern Lights 30 secs previewSEDONA, Ariz., Dec. 13, 2017 /PRNewswire/ — The sheer scale of the mountain is almost dizzying, yet Philippe Bergeron of LA-based PaintScaping is determined to map it.
“Quite frankly it feels overwhelming,” says Bergeron, as he prepares to head to Sedona AZ, to create “Sedona…

PR NEWSWIRE

Symmetry™: La expansión global alcanza un nuevo hito con el despliegue de la plataforma de Cloud Hosting HANA en Europa

Symmetry_LogoExpansión de la plataforma de vanguardia de Symmetry para soportar implementaciones críticas de SAP; las implementaciones de clientes entran en funcionamiento, incluido un fabricante líder de equipos industriales multinacionales
BROOKFIELD, Wisconsin y ÁMSTERDAM, 13 de diciembre de…

PR NEWSWIRE

Symmetrys™ weltweite Expansion erreicht mit der HANA Cloud-Hosting Plattformbereitstellung einen neuen Meilenstein in Europa

Symmetry_LogoErweiterung der modernsten Plattform von Symmetry, um kritische SAP-Implementierungen zu unterstützen; Kundeninstallierungen nehmen den Regelbetrieb auf, unter anderem bei einem führenden multinationalen Hersteller von Industrieanlagen
BROOKFIELD, Wisconsin und AMSTERDAM, 13. Dezember…

PR NEWSWIRE

L'expansion mondiale de Symmetry™ atteint une nouvelle étape avec le déploiement en Europe de la plateforme d'hébergement cloud HANA

Symmetry_LogoExpansion de la plateforme moderne de Symmetry pour soutenir les implémentations importantes de SAP ; entrée en service des déploiements de clients, notamment un grand fabricant multinational d’équipements industriels
BROOKFIELD, Wisconsin et AMSTERDAM, 13 décembre 2017 /PRNe…

PR NEWSWIRE

Regeneron Collaboration Programs Highlighted During Sanofi Analyst Day

TARRYTOWN, N.Y., Dec. 13, 2017 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced updates related to its collaboration programs with Sanofi, which were highlighted during Sanofi’s Sustaining Innovation Analyst Day in Paris, France.
In a separate release…

PR NEWSWIRE

Regeneron and Sanofi Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma

TARRYTOWN, N.Y. and PARIS, Dec. 13, 2017 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive topline results from a pivotal Phase 2 clinical study of cemiplimab in 82 patients with advanced cutaneous squamous cell carcinoma (CSCC), the second…

PR NEWSWIRE